Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Phase 3 Results for Long-acting Buprenorphine ...Yahoo FinanceThe present Phase 3 trial was a multicenter, randomized, double blind, double dummy, active controlled study that enrolled a total of 428 patients at 36 U.S.
